DT&CRO Co

DT&CRO Co OCF/Debt

The Operating Cash Flow to Debt Ratio of DT&CRO Co (383930.KQ) as of Oct 17, 2026 is -22.90 %. In the previous year, Operating Cash Flow to Debt Ratio was 102.45 % — a change of -122.35% (lower).

OCF/Debt

-22.90 %

YoY

-122.35%

Last updated:

Operating Cash Flow to Debt Ratio of DT&CRO Co is 2024 -22.90 % . Operating Cash Flow to Debt Ratio of DT&CRO Co was 2023 102.45 % . It decreases by -122.35% lower compared to the previous year.

The DT&CRO Co OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2019
4.32 KRW
Jan 1, 2020
3.12 KRW
Jan 1, 2022
102.45 KRW
Jan 1, 2024
-22.90 KRW
The DT&CRO Co OCF/Debt history
YEAROCF/DebtYoY
-22.90 %-122.35%
102.45 %+3,181.18%
3.12 %-27.80%
4.32 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DT&CRO Co Stock analysis

What does DT&CRO Co do? DT&CRO Co Ltd is a South Korean company operating in the Health Care sector, specifically within the Life Sciences Tools & Services industry. Based in Yongin, the company has 277 employees and completed its initial public offering (IPO) on November 11, 2022. DT&CRO Co Ltd provides non-clinical and clinical trial services for pharmaceuticals, medical devices, food, chemicals, and cosmetics. The company also offers analysis, efficacy evaluation, and related services. Its headquarters are located in Yongin, Gyeonggi-Do, South Korea. The company's website is www.dtncro.com. DT&CRO Co Ltd is engaged in research and development activities related to medicine and pharmaceuticals, though specific details about its R&D focus or product offerings are not provided in the available information. The company operates as a service provider in the life sciences sector, supporting various industries through trial services and analytical solutions. As a publicly traded company, it is listed under the ticker symbol 383930.KQ with ISIN KR7383930005. The company's operations are centered on delivering specialized services to clients in the pharmaceutical and related industries, emphasizing both non-clinical and clinical trial support. DT&CRO Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DT&CRO Co stock

Operating Cash Flow to Debt Ratio of DT&CRO Co is -22.90 % in 2024.

Operating Cash Flow to Debt Ratio of DT&CRO Co changed from 102.45 % to -22.90 %, representing a -122.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio DT&CRO Co since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's DT&CRO Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — DT&CRO Co

All Key Metrics — DT&CRO Co